Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SpaCe Trial: Gemcitabine/cisplatin with or without cetuximab in EGFR-positive pancreatic cancer
2004-004309-69Phase 2Completed
- Sponsor
- Fondazione Giscad per la Ricerca sui Tumori
- Start
- Dec 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of cetuximab in pancreatic cancer (PC) (2 arms), sponsored by Fondazione Giscad per la Ricerca sui Tumori. Started Dec 2006; status: completed.
02
Drugs
cetuximab
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on 2004-004309-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004309-69.